본문 바로가기
KERD
논문KCI 등재

Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

OBJECTIVES: The survival rate of human immunodeficiency virus (HIV)-infected patients receiving treatment in Ethiopia is poorly understood. This study aimed to determine the survival rate and predictors of mortality among HIV-infected adults on antiretroviral therapy (ART) at Jinka Hospital, South Omo, Ethiopia. METHODS: A 6-year retrospective cohort study was conducted using 350 patient records drawn from 1,899 patients on ART at Jinka Hospital from September 2010 to August 2015. The data were analyzed using Kaplan-Meier statistics and Cox regression models. RESULTS: Of the 350 study participants, 315 (90.0%) were censored and 35 (10.0%) died. Twenty-two (62.9%) of the deaths occurred during the first year of treatment. The total follow-up encompassed 1,995 person-years, with an incidence rate of 1.75 deaths per 100 person-years. The mean survival time of patients on highly active antiretroviral therapy (HAART) was 30.84±19.57 months. The overall survival of patients on HAART was 64.00% (95% confidence interval [CI], 61.85 to 66.21%) at 72 months of follow-up. The significant predictors of mortality included non-disclosure of HIV status (adjusted hazard ratio [aHR], 5.82; 95% CI, 1.91 to 17.72), a history of tuberculosis (aHR, 1.82; 95% CI, 1.41 to 3.51), and ambulatory (aHR, 2.97; 95% CI, 1.20 to 8.86) or bedridden (aHR, 4.67; 95% CI, 1.30 to 17.27) functional status, World Health Organization (WHO) clinical stage IV illness (aHR, 24.97; 95% CI, 2.75 to 26.45), and substance abusers (aHR, 3.72; 95% CI, 1.39 to 9.97). CONCLUSIONS: Patients with a history of tuberculosis treatment, ambulatory or bedridden functional status, or advanced WHO clinical stage disease, as well substance abusers, should be carefully monitored, particularly in the first few months after initiating antiretroviral therapy. Patients should also be encouraged to disclose their status to their relatives.

Abstract

OBJECTIVES: The survival rate of human immunodeficiency virus (HIV)-infected patients receiving treatment in Ethiopia is poorly understood. This study aimed to determine the survival rate and predictors of mortality among HIV-infected adults on antiretroviral therapy (ART) at Jinka Hospital, South Omo, Ethiopia. METHODS: A 6-year retrospective cohort study was conducted using 350 patient records drawn from 1,899 patients on ART at Jinka Hospital from September 2010 to August 2015. The data were analyzed using Kaplan-Meier statistics and Cox regression models. RESULTS: Of the 350 study participants, 315 (90.0%) were censored and 35 (10.0%) died. Twenty-two (62.9%) of the deaths occurred during the first year of treatment. The total follow-up encompassed 1,995 person-years, with an incidence rate of 1.75 deaths per 100 person-years. The mean survival time of patients on highly active antiretroviral therapy (HAART) was 30.84±19.57 months. The overall survival of patients on HAART was 64.00% (95% confidence interval [CI], 61.85 to 66.21%) at 72 months of follow-up. The significant predictors of mortality included non-disclosure of HIV status (adjusted hazard ratio [aHR], 5.82; 95% CI, 1.91 to 17.72), a history of tuberculosis (aHR, 1.82; 95% CI, 1.41 to 3.51), and ambulatory (aHR, 2.97; 95% CI, 1.20 to 8.86) or bedridden (aHR, 4.67; 95% CI, 1.30 to 17.27) functional status, World Health Organization (WHO) clinical stage IV illness (aHR, 24.97; 95% CI, 2.75 to 26.45), and substance abusers (aHR, 3.72; 95% CI, 1.39 to 9.97). CONCLUSIONS: Patients with a history of tuberculosis treatment, ambulatory or bedridden functional status, or advanced WHO clinical stage disease, as well substance abusers, should be carefully monitored, particularly in the first few months after initiating antiretroviral therapy. Patients should also be encouraged to disclose their status to their relatives.

참고문헌 (34)

  1. "Global report on AIDS statistics, information and facts about HIV AIDS"[URL]
  2. "AIDS by the numbers 2015"[URL]
  3. Chan KC, "Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002", HIV Med, 7, pp.186~192 (2006)
  4. Palella FJ Jr, "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators", N Engl J Med, 338, pp.853~860 (1998)
  5. "Global AIDS response progress reporting 2015"[URL]
  6. "Guideline for implementation of antiretroviral therapy in Ethiopia" (2005)[URL]
  7. "Ethiopia: HIV/ AIDS"[URL]
  8. Musa BM, "Incidence of tuberculosis and immunological profile of TB", HIV co-infected patients in Nigeria, 2015, pp.10, 185~192
  9. Setegn T, "Predictors of mortality among adult antiretroviral therapy users in southeastern Ethiopia : retrospective cohort study", AIDS Res Treat, 2015, pp.148769~ (2015)
  10. Assefa Y, "Outcomes of antiretroviral treatment program in Ethiopia : retention of patients in care is a major challenge and varies across health facilities", BMC Health Serv Res, 11, pp.81~ (2011)
  11. Weinberg A, "Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine", PLoS One, 10, pp.e0122431~ (2015)
  12. "Guidelines for implementation of the antiretroviral therapy programme in Ethiopia" (2007)[URL]
  13. "Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach" (2013)[URL]
  14. "Policy brief: consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: what’s new" (2015)[URL]
  15. Huisin ʼt Veld D, "Determinants of weight evolution among HIV-positive patients initiating antiretroviral treatment in low-resource settings", J Acquir Immune Defic Syndr, 70, pp.146~154 (2015)
  16. Wubshet M, "High loss to followup and early mortality create substantial reduction in patient retention at antiretroviral treatment program in north-west Ethiopia", ISRN AIDS, 2012, pp.721720~ (2012)
  17. Gebremedhin A, "Predictors of mortality among HIV infected children on anti-retroviral therapy in Mekelle Hospital, Northern Ethiopia: a retrospective cohort study", BMC Public Health, 13, pp.1047~ (2013)
  18. Desmonde S, "Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation", AIDS, 29, pp.1527~1536 (2015)
  19. Swanstrom AE, "Derivation and characterization of a CD4-independent, non-CD4-tropic simian immunodeficiency virus", J Virol, 90, pp.4966~4980 (2016)
  20. Tadesse K, "Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study", PLoS One, 9, pp.e87392~ (2014)
  21. Assefa Y, "Brief report: long-term outcomes and their determinants in patients on antiretroviral treatment in Ethiopia, 2005", 6-2011, J Acquir Immune Defic Syndr, pp.2015, 70[DOI]
  22. Damtew B, "Survival and determinants of mortality in adult HIV", Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia, 2015, pp.22, 138~
  23. Ebissa G, "Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia", AIDS Care, 27, pp.723~730 (2015)
  24. Mekuria LA, "Retention in HIV care and predictors of attrition from care among HIV-infected adults receiving combination anti-retroviral therapy in Addis Ababa", PLoS One, 10, pp.e0130649~ (2015)
  25. Dupont WD, "Power and sample size calculations. A review and computer program", Control Clin Trials, 11, pp.116~128 (1990)
  26. Mlangeni N, "Antiretroviral therapy programme outcomes in Tshwane district, South Africa: A 5-year retrospective study", S Afr Med J, 106, pp.51~52 (2016)
  27. Tsegaye E, "Assessment of antiretroviral treatment outcome in public hospitals, South Nations Nationalities and Peoples Region, Ethiopia", Ethiop J Health Dev, 25, pp.102~109 (2011)
  28. Teshome Yimer Y, "Magnitude and predictors of anti-retroviral treatment (ART) failure in private health facilities in Addis Ababa, Ethiopia", PLoS One, 10, pp.e0126026~ (2015)
  29. Patro SC, "Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG", Bcl2 family gene expression in chronically HIV-1-infected subjects, 2015, pp.89, 799~810
  30. Mellins CA, "Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth", AIDS Care, 24, pp.953~962 (2012)
  31. Wohlgemut J, "Trends in missed presentations and late HIV diagnosis in a UK teaching hospital : a retrospective comparative cohort study", BMC Infect Dis, 12, pp.72~ (2012)
  32. Biadgilign S, "Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia : a retrospective cohort study", AIDS Res Ther, 9, pp.15~ (2012)
  33. Milazzo L, "Short communication : impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV", HCV-coinfected patients treated with pegylated interferon plus ribavirin, 2012, pp.28, 989~993
  34. Etemad-Moghadam B, "Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus(SHIV-KB9)passaged in vivo", J Virol, 74, pp.4433~4440 (2000)

관련 논문AI추천

Effects of Antiretroviral Therapy on the Survival of Human Immunodeficiency Virus-positive Adult Patients in Andhra Pradesh, India: A Retrospective Cohort Study, 2007-2013Arvind Pandey, Himanshu Chaturvedi, Lakshmanan Jayaseelan, Laxmikant Chavan, Nicole Seguy, Pauline Harvey, Pinnamaneni Raj, Ram Bajpai대한예방의학회 · 예방의학회지2016 · 제49권 제6호Survival Trend of HIV/AIDS Patients Starting Antiretroviral Therapy in South Korea between 2001 and 2015기미경, 김민자, 김상일, 김수민, 김신우, 김용찬, 김효열, 박대원, 송준영, 안진영, 유명수, 최보율, 최윤수, 최준용, 최희정, 한명국연세대학교의과대학 · Yonsei Medical Journal2020 · 제61권 제8호Rapid Antiretroviral Therapy Initiation Reduces Mortality Among People Living With HIV in Indonesia: A Retrospective Observational StudyHendarwan Harimat, Lisdawati Vivi, Mauleti Ifael Yerosias, Mulyati Sri, Saptarini Ika, Syamsuridzal Djati Prasetio, Wibisana Krishna Adi대한예방의학회 · 예방의학회지2025 · 제58권 제4호Spatial inequalities and predictors of HIV/AIDS mortality risk in Hamadan, Iran: a retrospective cohort studyAmir Kavousi, Somayeh Momenyan한국역학회 · Epidemiology and Health2018 · 제40권 Life expectancy of HIV-positive patients after diagnosis in Iran from 1986 to 2016: a retrospective cohort study at national and sub-national levelsMohammad Mirzaei, Younes Mohammadi한국역학회 · Epidemiology and Health2018 · 제40권 Factors Associated With Long-term Retention in Antiretroviral Therapy Among People Living With HIV: Evidence From a Tertiary Hospital in Jakarta, IndonesiaHasiguan Armedy Ronny, Hendarwan Harimat, Lisdawati Vivi, Mauleti Ifael Yerosias, Mulyati Sri, Nurhayati, Saptarini Ika, Syamsuridzal Djati Prasetio, Wibisana Krishna Adi대한예방의학회 · 예방의학회지2024 · 제57권 제3호

이 간행물의 다른 논문 (58건)